Related Experiment Videos
Mn-DPDP enhanced MRI in experimental bile duct obstruction
Journal of Computer Assisted Tomography
|March 1, 1993
Summary
Bile duct obstruction significantly impairs manganese (Mn-DPDP) elimination, with the liver and kidneys unable to clear the contrast agent effectively. This study highlights the critical role of bile ducts in Mn-DPDP excretion.
Area of Science:
- Hepatobiliary imaging
- Pharmacokinetics
- Medical imaging contrast agents
Background:
- Hepatobiliary-specific contrast agents are crucial for diagnosing liver and bile duct diseases.
- Understanding the elimination pathways of contrast agents like Mn-DPDP is essential for accurate interpretation of imaging studies.
Purpose of the Study:
- To evaluate the effect of bile duct obstruction on the hepatobiliary contrast agent Mn-DPDP.
- To determine the roles of the liver and kidneys in the elimination of Mn-DPDP.
Main Methods:
- An animal study involving rats with varying degrees of bile duct ligation (common bile duct vs. selective lobe ligation) and a control group.
- Magnetic resonance imaging (MRI) T1-weighted sequences were used to assess signal enhancement over time after Mn-DPDP injection.
- Signal-to-noise ratio (S/N) plots were analyzed in the liver, spleen, and renal cortex.
Main Results:
- In normal rats, liver enhancement from Mn-DPDP returned to baseline within 24 hours.
- Rats with common bile duct ligation showed persistent liver enhancement for up to 21 days.
- Selective bile duct obstruction led to normalization of liver intensity within 3 days, while spleen and renal cortex showed similar enhancement patterns.
Conclusions:
- Bile duct obstruction severely hinders Mn-DPDP elimination from the body.
- Renal glomerular filtration is insufficient for clearing Mn-DPDP.
- Persistent enhancement in spleen and kidneys suggests Mn-DPDP or its metabolites bind to plasma proteins or are taken up by splenic/renal parenchyma.